← All Unity Biotechnology, INC filings

Unity Biotechnology, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

UBX
Unity Biotechnology, INC
10-K/A: Unity Biotechnology Files Amendment to 10-K, Updates Executive and Director Information
Unity Biotechnology files an amendment to its 2024 Annual Report on Form 10-K to include updated information on directors, executive officers, compensation, and related matters.
UBX
Unity Biotechnology, INC
10-K: Unity Biotechnology's 10-K Filing Reveals Focus on UBX1325 and Financial Challenges
Unity Biotechnology's 10-K filing highlights the company's strategic focus on UBX1325 for ophthalmologic diseases amid financial uncertainties and a need for additional funding.
UBX
Unity Biotechnology, INC
10-K: Unity Biotechnology Amends Director Compensation Program and Files Annual Report
Unity Biotechnology updates its non-employee director compensation program and files its annual report on Form 10-K, detailing financial results and business activities.